James L. Karagianis, MD, FRCP(C)

Letter to the Editor

Development of an Atherogenic Metabolic Risk Factor Profile Associated With the Use of Atypical Antipsychotics.

January 15, 2005

Letter to the Editor

Reply to "Possible Impact of Dropout in a Study ofHigh-Dose Olanzapine and Prolactin Levels"

August 16, 2004

Original Research

High-Dose Olanzapine and Prolactin Levels

October 15, 2003

Article

Rapid Tranquilization With Olanzapine in Acute Psychosis: A Case Series

February 1, 2001